Rankings
▼
Calendar
GPCR Q1 2024 Earnings — Structure Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
GPCR
Structure Therapeutics Inc.
$3B
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$32M
Net Income
-$26M
EPS (Diluted)
$-0.57
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$34M
Free Cash Flow
-$34M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$457M
Total Liabilities
$27M
Stockholders' Equity
$430M
Cash & Equivalents
$98M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$32M
-$20M
-62.9%
Net Income
-$26M
-$18M
-44.8%
← FY 2024
All Quarters
Q2 2024 →